. 2007 Oct 2;63(12):1171–1177. doi: 10.1007/s00228-007-0362-9

Table 3.

Selection of drugs from the seven groups, classification of guideline drugs and non-guideline drugs mostly encountered

Group of drugs	ATC		Guideline drugs	Mostly encountered non-guideline drugs in our study population
HMG CoA reductase inhibitors	C10AA	C10AA01, C10AA03	Simvastatin, Pravastatin	Fluvastatin, Rosuvastatin, Atorvastatin
Drugs for acid-related diseases^a	A02	A02A, A02BA	Antacids, H2-receptor antagonists	Proton pump inhibitors
Antibacterials for systemic use	J01	J01A, J01B	Tetracyclines, Amfenicoles	Quinolone antibacterials
		J01C except J01CR02	Beta-lactam antibacterials except amoxicilline and enzyme inhibitor	Amoxiciline and enzyme inhibitor
		J01C except J01CR02		Cefalosporins
		J01E	Sulfonamids and Trimethoprim
		J01F	Macrolides, lincosamides, streptogramins
		J01X	Other antibacterials (e.g. Fusidic acid)
Antidepressants	N06A	N06AA09, N06AA02	Amitryptiline, Imipramine	Maprotiline, Clomipramine, Fluoxetine
		N06AA10, N06AB08	Nortriptyline, Fluvoxamine	Citalopram, Trazodone, Venlafaxine, Mirtazapin
		N06AB05, N06AB06	Paroxetine, Sertraline	Citalopram, Trazodone, Venlafaxine, Mirtazapin
Benzodiazepine derivatives and related drugs^b	N05BA	N05CD07, N05CF02	Temazepam, Zolpidem	Triazolam, Lormetazepam, Flunitrazepam, Loprazolam, Clobazam, Bromazepam, Lorazepam, Oxazepam, Chloordiazepoxide, Alprazolam, Zopiclone
	N05CD	N05BA01	Diazepam
	N05CF	N05BA01	Diazepam
Drugs for obstructive airway diseases	R03	R03AC	Selective beta-2-adrenoreceptor agonists	Adrenergis for systemic use, Theophylline,
		R03AC	Selective beta-2-adrenoreceptor agonists	Montelukast
		R03BA, R03BB	Glucocorticoids, Anticholinergics
		R03BC01	Cromoglicic acid
Oral blood glucose lowering drugs	A10B	A10BB	Sulfonamides, urea derivatives	Repaglinide, Thiazolidinediones
Oral blood glucose lowering drugs	A10B	A10BA02, A10BF01	Metformin, Acarbose	Repaglinide, Thiazolidinediones

^aDrugs of first choice according to the corresponding NHG standard were only suitable for patients without use of NSAIDs. Therefore, for the index of adherence of the antacids, special DU90% segments had to be calculated for all PTAMs, with the additional postulation that only first deliveries of selected GPs were included for those patients who had not had a prescription of a NSAID in the preceding 4 months.

^bThe valid NHG standard for hypnotics dated from 1992 and was quite obsolete. To better meet the actual standards and recommendations, we labelled the guideline drugs, recommended by another commonly used standard [23].